Suvretta Capital Management’s Charles River Laboratories CRL Stock Holding History

Suvretta Capital Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$229K	Buy	+1,010	New	+$180K	﹤0.01%	95
2026 Q1	–	Sell	-1,010	Closed	-$201K	–	93
2025 Q4	$201K	Buy	+1,010	New	+$183K	﹤0.01%	93
2024 Q3	–	Sell	-1,010	Closed	-$209K	–	101
2024 Q2	$209K	Hold	1,010	–	–	0.01%	97
2024 Q1	$274K	Hold	1,010	–	–	0.01%	101
2023 Q4	$239K	Buy	+1,010	New	+$199K	0.01%	87
2023 Q3	–	Sell	-1,010	Closed	-$212K	–	92
2023 Q2	$212K	Hold	1,010	–	–	0.01%	98
2023 Q1	$204K	Hold	1,010	–	–	0.01%	93
2022 Q4	$220K	Buy	+1,010	New	+$221K	0.01%	86

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Suvretta Capital Management's CRL Position: Q2 2026 in Review

Suvretta Capital Management opened a new position in Charles River Laboratories (CRL) in Q2 2026: 1,010 shares worth $229K. The stake represents ﹤0.01% of the portfolio and ranks #95 among its holdings. This is a return to the name: Suvretta Capital Management previously reported a position in CRL as recently as Q4 2025.

Suvretta Capital Management first reported a position in CRL in Q4 2022 and has held it in 8 quarters since. The position peaked at $274K in Q1 2024. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Suvretta Capital Management held 1,010 shares of Charles River Laboratories worth $229K as of Q2 2026.
Charles River Laboratories was a new Suvretta Capital Management position in Q2 2026.
Charles River Laboratories made up ﹤0.01% of Suvretta Capital Management's portfolio in Q2 2026, its #95 holding.
Suvretta Capital Management first reported a position in Charles River Laboratories in Q4 2022 and has held it in 8 quarters since.
Suvretta Capital Management's Charles River Laboratories position peaked at $274K in Q1 2024.
563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Suvretta Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.